Press Releases about Astrazeneca Plc ADR
AbbVie Stock: Dividend King ABBV Overview
January 19, 2023
Via MarketBeat
Tempus Announces Prospective Study for Biomarker Discovery in Small Cell Lung Cancer
January 05, 2023
From Tempus
Via Business Wire
From AstraZeneca
Via Business Wire
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
November 30, 2022
Via MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
AstraZeneca EVUSHELD Named on TIME’s List of the Best Inventions of 2022
November 10, 2022
From AstraZeneca
Via Business Wire
From AstraZeneca
Via Business Wire
From AstraZeneca
Via Business Wire
Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028
October 12, 2022
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|